Table 3. Lung cancer incidence rate ratios1 for all lung cancers and histologic cell-types by nSES for females according to race/ethnicity, California 2008–2012.
| Hispanic | AAPI2 | Black | White | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nSES2 | Cases | IRR2 | (95% CI2) | Cases | IRR | (95% CI) | Cases | IRR | (95% CI) | Cases | IRR | (95% CI) | |
| Overall lung cancer | Q4-high | 528 | 1.00 | reference | 1,177 | 1.00 | reference | 254 | 1.00 | reference | 7,680 | 1.00 | reference |
| Q3 | 878 | 0.95 | (0.85, 1.06) | 1,008 | 0.97 | (0.89, 1.06) | 526 | 1.09 | (0.93, 1.27) | 7,644 | 1.18 | (1.14, 1.22) | |
| Q2 | 1,086 | 0.81 | (0.73, 0.91) | 878 | 1.00 | (0.91, 1.09) | 807 | 1.31 | (1.13, 1.52) | 6,717 | 1.32 | (1.27, 1.36) | |
| Q1-low | 1,397 | 0.79 | (0.71, 0.88) | 571 | 1.09 | (0.98, 1.21) | 1,117 | 1.43 | (1.25, 1.66) | 3,906 | 1.68 | (1.61, 1.75) | |
| Adenocarcinoma | Q4-high | 320 | 1.00 | reference | 885 | 1.00 | reference | 148 | 1.00 | reference | 4,312 | 1.00 | Reference |
| Q3 | 487 | 0.87 | (0.75, 1.00) | 713 | 0.92 | (0.83, 1.01) | 268 | 0.94 | (0.76, 1.17) | 3,771 | 1.04 | (0.99, 1.08) | |
| Q2 | 558 | 0.69 | (0.59, 0.79) | 624 | 0.94 | (0.85, 1.05) | 410 | 1.15 | (0.94, 1.40) | 3,116 | 1.09 | (1.04, 1.14) | |
| Q1-low | 719 | 0.67 | (0.59, 0.77) | 388 | 1.00 | (0.88, 1.13) | 491 | 1.08 | (0.89, 1.31) | 1,593 | 1.23 | (1.15, 1.30) | |
| SCC2 | Q4-high | 57 | 1.00 | reference | 72 | 1.00 | reference | 26 | 1.00 | reference | 1,010 | 1.00 | Reference |
| Q3 | 105 | 1.06 | (0.76, 1.49) | 79 | 1.21 | (0.87, 1.71) | 85 | 1.80 | (1.13, 2.96) | 1,285 | 1.49 | (1.37, 1.62) | |
| Q2 | 166 | 1.12 | (0.83, 1.56) | 93 | 1.72 | (1.25, 2.39) | 135 | 2.32 | (1.50, 3.73) | 1,204 | 1.77 | (1.62, 1.93) | |
| Q1-low | 216 | 1.11 | (0.82, 1.52) | 46 | 1.35 | (0.91, 2.00) | 229 | 3.06 | (2.00, 4.84) | 809 | 2.58 | (2.34, 2.84) | |
| SCLC2 | Q4-high | 46 | 1.00 | reference | 37 | 1.00 | reference | 21 | 1.00 | reference | 730 | 1.00 | Reference |
| Q3 | 83 | 1.01 | (0.70, 1.49) | 40 | 1.12 | (0.69, 1.82) | 48 | 1.20 | (0.70, 2.14) | 938 | 1.52 | (1.38, 1.69) | |
| Q2 | 115 | 1.01 | (0.71, 1.47) | 40 | 1.32 | (0.82, 2.15) | 86 | 1.60 | (0.97, 2.75) | 959 | 1.96 | (1.77, 2.17) | |
| Q1-low | 162 | 1.06 | (0.75, 1.51) | 31 | 1.75 | (1.04, 2.93) | 141 | 2.07 | (1.29, 3.50) | 625 | 2.82 | (2.53, 3.16) | |
| LC+OSC2 | Q4-high | 52 | 1.00 | reference | 55 | 1.00 | reference | 18 | 1.00 | reference | 623 | 1.00 | Reference |
| Q3 | 88 | 0.97 | (0.67, 1.40) | 50 | 1.06 | (0.71, 1.60) | 41 | 1.11 | (0.62, 2.10) | 595 | 1.15 | (1.02, 1.29) | |
| Q2 | 108 | 0.82 | (0.58, 1.17) | 41 | 1.03 | (0.67, 1.59) | 59 | 1.27 | (0.73, 2.32) | 516 | 1.26 | (1.12, 1.43) | |
| Q1-low | 116 | 0.68 | (0.48, 0.96) | 29 | 1.21 | (0.74, 1.97) | 91 | 1.62 | (0.96, 2.91) | 316 | 1.70 | (1.47, 1.96) | |
| Unspecified | Q4-high | 53 | 1.00 | reference | 128 | 1.00 | reference | 41 | 1.00 | reference | 1,005 | 1.00 | Reference |
| Q3 | 115 | 1.21 | (0.86, 1.72) | 126 | 1.09 | (0.84, 1.41) | 84 | 1.07 | (0.72, 1.62) | 1,055 | 1.24 | (1.13, 1.36) | |
| Q2 | 139 | 1.02 | (0.74, 1.44) | 80 | 0.81 | (0.60, 1.09) | 117 | 1.13 | (0.78, 1.68) | 922 | 1.39 | (1.26, 1.52) | |
| Q1-low | 184 | 1.01 | (0.74, 1.41) | 77 | 1.28 | (0.95, 1.72) | 165 | 1.27 | (0.89, 1.86) | 563 | 1.85 | (1.67, 2.06) | |
1. Bold type indicates statistical significance
2. AAPI, Asian American/Pacific Islander; nSES, neighborhood socioeconomic status; IRR, incidence rate ratio; CI, confidence interval; SCC, squamous cell carcinoma; SCLC, small cell lung cancer; LC+OSC, large cell and other cell lung cancer